Daily Archives :

Wednesday, May 15, 2024

ICH Q14 analytical development guideline

May 15, 2024

Leveraging ICH Q14 for Analytical Development

What’s new with the ICH Q14 for Analytical development?To regulate drug production, there are a multitude of documents that pharmaceutical companies can refer

https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg 1200 900 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/04/AMC_News_ICHQ14-1.jpg May 15, 2024 March 4, 2025

May 15, 2024

ISCT

Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to ISCT 2024 in Vancouver

https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg 2400 1800 Anemocyte.com Anemocyte.com https://anemocyte.com/wp-content/uploads/2024/03/AMC_News_ISCT-2024-–-3@2x.jpg May 15, 2024 April 23, 2025

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | Anemocyte Inc. 1221 Brickell Avenue, Suite 1160 Miami FL 33131

VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961

Privacy & cookie Policy